BioVaria Start-up Awards go to ISD Immunotech and Mindpax.me
The winners of this year’s ‘Startup Pitch & Partner Competition’ are ISD Immunotech, in the category ‘Emerging’, and Mindpax.me, in the category ‘Rising’. They were selected by a jury of first-tier venture capitalists for their outstanding presentations, their promising technologies and their business concepts. ISD Immunotech, a spin-out from Aarhus University, Denmark, pursues a novel approach for the treatment of severe SLE (systemic lupus erythematosus), an autoimmune disease that so far lacks specific treatment options. Mindpax.me develops a digital solution for monitoring individual biorhythms to help prevent mental health attacks. It holds strong potential to improve quality of life for millions of patients, while considerably reducing healthcare costs. ‘We are delighted to accept the Biovaria Emerging Startup award. It will help us attract the recognition and financing required to develop the first safe and effective therapy for lupus patients,’ said Tara Heitner, CEO of ISD. Pavel Nevický, co-founder of Mindpax.me continued: ‘We are honoured to be chosen best Rising Startup at BioVaria, and the award strengthens our determination to apply digital diagnostic tools to the treatment of severe mental health disorders.’
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.